Loading...
BioLife Q1 2025 Earnings Report
BioLife Solutions reports strong first quarter 2025 financial results with significant growth in cell processing revenue and improved profitability.
Key Takeaways
BioLife Solutions delivered a strong start to 2025, with total revenue increasing by 30% year-over-year to $23.9 million, primarily driven by a 33% growth in cell processing platform revenue. The company also significantly improved its profitability, reporting a GAAP net loss of $0.4 million and non-GAAP adjusted EBITDA of $5.7 million, or 24% of revenue.
Cell Processing revenue increased by 33% over Q1 2024, reaching $21.6 million.
Non-GAAP adjusted EBITDA grew to $5.7 million, representing 24% of revenue, up from 14% in Q1 2024.
The company processed 13 new U.S. FDA Master File cross references for its biopreservation media, bringing the cumulative total to 782.
BioLife Solutions completed the acquisition of PanTHERA CryoSolutions, enhancing its position as a biopreservation market leader.
BioLife
BioLife
BioLife Revenue by Segment
Revenue by Segment
Cell Processing platform Revenue
CapyFin.comevo and Thaw platform Revenue
CapyFin.com Forward Guidance
BioLife Solutions is affirming its 2025 revenue guidance of $95.5 million to $99.0 million, representing growth of 16% to 20% compared with 2024, with expectations for continued gross margin expansion and a reduction in net loss.
Positive Outlook
- Expected year-over-year revenue growth of 16% to 20% for 2025.
- Cell Processing platform revenue expected to grow 18% to 21% year-over-year.
- Anticipated GAAP gross margin in the low 60% range.
- Anticipated adjusted gross margin (non-GAAP) in the mid-60% range.
- Expected reduction in net loss (GAAP) and continued expansion of adjusted EBITDA margin (non-GAAP) compared with 2024.
Challenges Ahead
- No specific negative forward guidance points were highlighted in the provided text.
- No specific negative forward guidance points were highlighted in the provided text.
- No specific negative forward guidance points were highlighted in the provided text.
- No specific negative forward guidance points were highlighted in the provided text.
- No specific negative forward guidance points were highlighted in the provided text.
Revenue & Expenses
Visualization of income flow from segment revenue to net income